Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention

被引:0
作者
P E Ferguson
C F C Jordens
N M Gilroy
机构
[1] Centre for Infectious Diseases and Microbiology and NHMRC Clinical Centre for Research Excellence in Bioethics and Haematological Malignancies,
[2] Westmead Hospital,undefined
[3] Centre for Values,undefined
[4] Ethics and the Law in Medicine,undefined
[5] The University of Sydney,undefined
[6] NHMRC Clinical Centre for Research Excellence in Bioethics and Haematological Malignancies,undefined
[7] Westmead Hospital,undefined
来源
Bone Marrow Transplantation | 2010年 / 45卷
关键词
influenza vaccination; hematopoietic SCT; patient education; evaluative research; respiratory viruses;
D O I
暂无
中图分类号
学科分类号
摘要
To prevent respiratory virus (RV) infection after hematopoietic SCT (HSCT), patient and household members are advised to have annual influenza vaccinations and avoid symptomatic contacts. The object of this study was to measure and increase patient/household awareness of RV infection and preventive measures. We used a self-administered questionnaire before/after a 5-min educational module (2006–2007) and interviews with HSCT patients (2005–2007). The subjects were patients and their households attending pre-HSCT education in an Australian HSCT Unit. Outcome measures were awareness of RV infection post-HSCT and effective prevention strategies; household influenza vaccination on admission for HSCT. In all, 139 out of 205 (68%) participants completed both questionnaires. Baseline knowledge of RV infection risk was high; knowledge of prevention was low. Intervention increased awareness that influenza post-HSCT could be fatal or require intensive care (68–87%, P=0.003), knowledge of effective prevention strategies (41–78%, P<0.0001) including vaccination (11–58%, P<0.0001), and belief among family/friends (but not patients) that household vaccination reduces influenza risk post-HSCT (57–97%, P<0.0001 and 76–81%, P=0.2, respectively). Household vaccination at HSCT admission was 71% for attenders and 30% for non-participants (RR 2.38, 95% confidence interval (CI) 1.49–3.80, P<0.0001). We concluded that patient and family pre-HSCT education increases awareness of RV prevention strategies and household influenza vaccination.
引用
收藏
页码:656 / 661
页数:5
相关论文
共 96 条
[1]  
Roghmann M(2003)Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation Bone Marrow Transplant 32 1085-1088
[2]  
Ball K(2005)Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture Clin Infect Dis 40 662-669
[3]  
Erdmann D(2005)Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies Am Soc Blood Marrow Transplant 11 781-796
[4]  
Lovchik J(2001)Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 28 479-484
[5]  
Anderson LJ(1997)Respiratory viral infections in immunocompetent and immunocompromised persons Am J Med 102 2-9
[6]  
Edelman R(1996)Community respiratory virus infections among hospitalized adult bone marrow transplant recipients Clin Infect Dis 22 778-782
[7]  
van Kraaij MGJ(2004)Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality and the effect of antiviral therapy Clin Infect Dis 39 1300-1306
[8]  
van Elden LJR(2004)Use of oseltamivir to control influenza complications after bone marrow transplantation Bone Marrow Transplant 34 111-114
[9]  
van Loom AM(2009)Global transmission of oseltamivir-resistant influenza N Engl J Med 360 953-956
[10]  
Hendriksen KA(2007)Recovery of drug-resistant influenza virus from immunocompromised patients: a case series J Infect Dis 193 760-764